The DOI matches its Crossref record, with a small difference in title or year; 37 of the 37 references it cites were found in a registry or an index.
Factor Analysis of Metabolic Syndrome Using Directly Measured Insulin Sensitivity
Open accessAbstract
Factor analysis, a multivariate correlation technique, has been used to provide insight into the underlying structure of metabolic syndrome, which is characterized by physiological complexity and strong statistical intercorrelation among its key variables. The majority of previous factor analyses, however, have used only surrogate measures of insulin sensitivity. In addition, few have included members of multiple ethnic groups, and only one has presented results separately for subjects with impaired glucose tolerance. The objective of this study was to investigate, using factor analysis, the clustering of physiologic variables using data from 1,087 nondiabetic participants in the Insulin Resistance Atherosclerosis Study (IRAS). This study includes information on the directly measured insulin sensitivity index (SI) from intravenous glucose tolerance testing among African-American, Hispanic, and non-Hispanic white subjects aged 40–69 years at various stages of glucose tolerance. Principal factor analysis identified two factors that explained 28 and 9% of the variance in the dataset, respectively. These factors were interpreted as 1) a “ metabolic” factor, with positive loadings of BMI, waist, fasting and 2-h glucose, and triglyceride and inverse loadings of log(SI+1) and HDL; and 2) a “blood pressure” factor, with positive loadings of systolic and diastolic blood pressure. The results were unchanged when surrogate measures of insulin resistance were used in place of log(SI+1). In addition, the results were similar within strata of sex, glucose tolerance status, and ethnicity. In conclusion, factor analysis identified two underlying factors among a group of metabolic syndrome variables in this dataset. Analyses using surrogate measures of insulin resistance suggested that these variables provide adequate information to explore the underlying intercorrelational structure of metabolic syndrome. Additional clarification of the physiologic characteristics of metabolic syndrome is required as individuals with this condition are increasingly being considered candidates for behavioral and pharmacologic intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Factor analysis in epidemiological studies in different populations, including adolescents and ethnic minorities, demonstrates clustering of risk in the domains of adiposity and/or dyslipidemia, hyperglycemia or insulin resistance, and hypertension that explain 37% to 70% of variation and vary by sex and race (4-7).”
From The CardioMetabolic Health Alliance (2015) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Coated Charcoal Immunoassay of Insulin
Herbert, V. D., Lau, K., Gottlieb, C. W., & Bleicher, S. J. (1965) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-25-10-1375 · Cited by 2,969
Assessment of Insulin Sensitivityin Vivo*
Bergman, R. N., Finegood, D. T., & Ader, M. (1985) · Endocrine Reviews · doi:10.1210/edrv-6-1-45 · Cited by 1,072
How good a marker is insulin level for insulin resistance?
Laakso, M. (1993) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116768 · Cited by 726
(1999) · Diabetes Care · doi:10.2337/diacare.22.4.623 · Cited by 725
Pacini, G., & Bergman, R. N. (1986) · Computer Methods and Programs in Biomedicine · doi:10.1016/0169-2607(86)90106-9 · Cited by 695
Haffner, S. M., Ralph, D., Saad, M. F., Rewers, M., Mykkänen, L., Selby, J., Howard, G., Savage, P. J., Hamman, R. F., Wegenknecht, L. E., et al. (1996) · Diabetes · doi:10.2337/diab.45.6.742 · Cited by 536
Self-citationRisk Variable Clustering in the Insulin Resistance Syndrome: The Framingham Offspring Study
Meigs, J. B., D’Agostino, R. B., Wilson, P. W. F., Cupples, L. A., Nathan, D. M., & Singer, D. E. (1997) · Diabetes · doi:10.2337/diacare.46.10.1594 · Cited by 525
Self-citationLemieux, S., Prud'homme, D., Bouchard, C., Tremblay, A., & Despres, J. (1996) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/64.5.685 · Cited by 519
The Insulin Resistance Atherosclerosis Study (IRAS)
Wagenknecht, L. E., Mayer, E. J., Rewers, M., Haffner, S. M., Selby, J. V., Borok, G. M., Henkin, L. F., Howard, G., Savage, P. J., Saad, M. F., et al. (1995) · Annals of Epidemiology · doi:10.1016/1047-2797(95)00062-3 · Cited by 494
Self-citationFerrannini, E. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.4.0336 · Cited by 451
Sakkinen, P. A., WAHL, P. W., Cushman, M., Lewis, M. R., & Tracy, R. P. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.10.897 · Cited by 420
Self-citationMeigs, J. B. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.10.908 · Cited by 397
Saad, M. F., Anderson, R. L., Laws, A., Watanabe, R. M., Kades, W. W., Chen, Y. D. I., Sands, R. E., Pei, D., Savage, P. J., & Bergman, R. N. (1994) · Diabetes · doi:10.2337/diab.43.9.1114 · Cited by 376
Self-citationFactor Analysis: An Applied Approach
Jackson, J. E. (1985) · Technometrics · doi:10.1080/00401706.1985.10488039 · Cited by 372
Festa, A., D'agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00331.x · Cited by 364
Self-citationPyörälä, M., Miettinen, H., Halonen, P. M., Laakso, M., & Pyörälà, K. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.2.538 · Cited by 349
WELCH, S., Gebhart, S. S. P., Bergman, R. N., & Phillips, L. S. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-6-1508 · Cited by 340
Insulin Resistance Syndrome Predicts Coronary Heart Disease Events in Elderly Nondiabetic Men
Lempiäinen, P., Mykkänen, L., Pyörälä, K., Laakso, M., & Kuusisto, J. (1999) · Circulation · doi:10.1161/01.cir.100.2.123 · Cited by 293
Chen, W., Srinivasan, S. R., Elkasabany, A., & Berenson, G. S. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010069 · Cited by 266
Hyperleptinemia as a Component of a Metabolic Syndrome of Cardiovascular Risk
Leyva, F., Godsland, I. F., Ghatei, M. A., Proudler, A. J., Aldis, S., Walton, C., Bloom, S. R., & Stevenson, J. C. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.6.928 · Cited by 254
Steil, G., Vølund, A., Kahn, S., & Bergman, R. (1993) · Diabetes · doi:10.2337/diab.42.2.250 · Cited by 234
Chiasson, J.-L., Gomis, R., Hanefeld, M., Josse, R. G., Karasik, A., Laakso, M., & The Stop-Niddm Trial Research Group (1998) · Diabetes Care · doi:10.2337/diacare.21.10.1720 · Cited by 182
Risk Factor Clustering in the Insulin Resistance Syndrome: The Strong Heart Study
Gray, R. S., Fabsitz, R. R., Cowan, L. D., Lee, E. T., Howard, B. V., & Savage, P. J. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009712 · Cited by 166
Self-citationMultivariate analysis of the insulin resistance syndrome in women.
Edwards, K. L., Austin, M. A., Newman, B. M., Mayer, E. J., Krauss, R. M., & Selby, J. V. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.12.1940 · Cited by 159
Anderson, R. L., Hamman, R. F., Savage, P. J., Saad, M. F., Laws, A., Kades, W. W., Sands, R., & Cefalu, W. T. (1995) · American Journal of Epidemiology · doi:10.1093/aje/142.7.724 · Cited by 138
Self-citationHaffner, S. M., D’Agostino, R. B., Saad, M. F., et al. (1996) · Diabetes · doi:10.2337/diabetes.45.6.742 · Cited by 116
Self-citationGodsland, Leyva, Walton, C., Worthington, & Stevenson (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00312.x · Cited by 112
Kekäläinen, P., Sarlund, H., Pyörälà, K., & Laakso, M. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.86 · Cited by 89
Factors of the Insulin Resistance Syndrome in Nondiabetic and Diabetic Elderly Japanese-American Men
Edwards, K. L., Burchfiel, C. M., Sharp, D. S., Curb, J. D., Rodríguez, B. L., Fujimoto, W. Y., LaCroix, A. Z., Vitiello, M. V., & Austin, M. A. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009469 · Cited by 83
Shmulewitz, D., Auerbach, S. B., Lehner, T., Blundell, M. L., Winick, J. D., Youngman, L. D., Skilling, V. A., Heath, S. C., Ott, J., Stoffel, M., et al. (2000) · Human Heredity · doi:10.1159/000022953 · Cited by 80
Chen, C., Lin, K., Tsai, S.-T., & Chou, P. (2000) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)00255-7 · Cited by 68
Does Insulin Resistance Unite the Separate Components of the Insulin Resistance Syndrome?
Donahue, R. P., Bean, J. A., Donahue, R. A. D., Goldberg, R. B., & Prineas, R. J. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.11.2413 · Cited by 68
Burke, J. P., Williams, K. C., Haffner, S., Villalpando, C., & Stern, M. P. (2001) · Diabetes Care · doi:10.2337/diacare.24.9.1573 · Cited by 61
Self-citationSnehalatha, C., Sivasankari, S., Satyavani, K., Viswanathan, V., & Ramachandran, A. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00239.x · Cited by 50
Chen, W. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)01274-7 · Cited by 23
Cited by
Sorted by citations
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,317
Eckel, R. H., Grundy, S. M., & Zimmet, P. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,755
The Metabolic Syndrome: Time for a Critical Appraisal
Kahn, R., Buse, J. B., Ferrannini, E., & Stern, M. P. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2289 · Cited by 2,400
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
Grundy, S. M. (2010) · Springer eBooks · doi:10.1007/978-1-4419-5839-6_1 · Cited by 1,227
Metadata
- Authors
- Hanley, A. J. G., Karter, A. J., Festa, A., D’Agostino, R., Wagenknecht, L. E., Savage, P., Tracy, R. P., Saad, M. F., & Haffner, S.
- Affiliations
- Mount Sinai Hospital (CA)
- Kaiser Permanente (US)
- The University of Texas at San Antonio Health Science Center (US)
- Wake Forest University Health Sciences (US)
- National Heart, Lung, and Blood Institute (US)
- University of Vermont (US)
- University of Southern California (US)
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2002-08-01
- Volume
- 51
- Issue
- 8
- Pages
- 2642-2647
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2120101762
- Cited by
- 229
- References
- 36
- Citations by year
- 2025: 2 · 2024: 4 · 2023: 1 · 2022: 3 · 2021: 5 · 2020: 6 · 2018: 6 · 2017: 6 · 2016: 5 · 2015: 5 · 2014: 12 · 2013: 8 · 2012: 15
- FWCI
- 10.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- National Institutes of Health (5u01hl047887-09, 5u01hl047889-09)
- Genentech
- U.S. Public Health Service (R01-58329)
- Canadian Institutes of Health Research
- National Heart, Lung, and Blood Institute (U01HL047902, U01-HL 47889, U01-HL 47887, U01HL047892, DK-29867)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK029867, DK29867)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- metabolic syndrome, insulin sensitivity, insulin resistance, factor structure, impaired glucose tolerance, blood pressure, body mass index, waist circumference, triglycerides, HDL cholesterol, African Americans, Hispanic Americans, Insulin Resistance Atherosclerosis Study
- MeSH terms
- Arteriosclerosis, Body Constitution, Cardiovascular Diseases, Creatinine, Ethnicity, Factor Analysis, Statistical, Female, Humans, Hypertension, Insulin, Insulin Resistance, Male, Middle Aged, Risk Factors, Smoking, Triglycerides, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review